The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Androgen content and BET bromodomain proteins influence enzalutamide agonism of mutant F876L androgen receptor.
 
Daniel J. Coleman
No Relationships to Disclose
 
Kathryn Van Hook
No Relationships to Disclose
 
Carly J. King
No Relationships to Disclose
 
Jacob Schwartzman
No Relationships to Disclose
 
Robert Lisac
No Relationships to Disclose
 
Joshua Urrutia
No Relationships to Disclose
 
Archana Sehrawat
No Relationships to Disclose
 
Josha Woodward
No Relationships to Disclose
 
Nicholas J. Wang
No Relationships to Disclose
 
Roman Gulati
No Relationships to Disclose
 
George V. Thomas
No Relationships to Disclose
 
Tomasz M. Beer
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Research & Development (Inst); Medivation (Inst); OncoGenex (Inst); Sotio; Sotio (Inst)
 
Martin E. Gleave
No Relationships to Disclose
 
James E. Korkola
No Relationships to Disclose
 
Lina Gao
No Relationships to Disclose
 
Laura M. Heiser
No Relationships to Disclose
 
Joshi J. Alumkal
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Millennium (Inst); Novartis (Inst)